AdaptHealth Corp. Quarterly Income Tax Expense (Benefit) in USD from Q1 2018 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
AdaptHealth Corp. quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q1 2018 to Q2 2024.
  • AdaptHealth Corp. Income Tax Expense (Benefit) for the quarter ending June 30, 2024 was $7.25M, a 34.2% increase year-over-year.
  • AdaptHealth Corp. Income Tax Expense (Benefit) for the twelve months ending June 30, 2024 was -$38.8M, a 377% decline year-over-year.
  • AdaptHealth Corp. annual Income Tax Expense (Benefit) for 2023 was -$49M, a 298% decline from 2022.
  • AdaptHealth Corp. annual Income Tax Expense (Benefit) for 2022 was $24.8M, a 24.5% decline from 2021.
  • AdaptHealth Corp. annual Income Tax Expense (Benefit) for 2021 was $32.8M.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 -$38.8M $7.25M +$1.85M +34.2% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-06
Q1 2024 -$40.7M $6.61M +$8.32M Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-07
Q4 2023 -$49M -$18.1M -$22.8M -483% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-27
Q3 2023 -$26.2M -$34.6M -$40.2M -720% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-07
Q2 2023 $14M $5.4M -$3.45M -39% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-06
Q1 2023 $17.5M -$1.71M -$7.32M -131% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q4 2022 $24.8M $4.73M -$5.29M -52.8% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-27
Q3 2022 $30.1M $5.58M -$6.57M -54.1% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-07
Q2 2022 $36.6M $8.85M -$3.48M -28.2% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 $40.1M $5.6M +$7.3M Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 $32.8M $10M +$17.2M Oct 1, 2021 Dec 31, 2021 10-K 2024-02-27
Q3 2021 $15.6M $12.1M +$17.1M Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 -$1.51M $12.3M +$10.5M +575% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 -$12M -$1.7M -$54K -3.29% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q4 2020 -$12M -$7.22M -$2.51M -53.5% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-28
Q3 2020 -$9.44M -$4.92M -$5.95M -579% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-09
Q2 2020 -$3.49M $1.83M -$172K -8.61% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-06
Q1 2020 -$3.32M -$1.64M -$4.06M -168% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-10
Q4 2019 $739K -$4.7M -$2.06M -77.9% Oct 1, 2019 Dec 31, 2019 10-K 2022-03-01
Q3 2019 $2.8M $1.03M +$785K +325% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-06
Q2 2019 $2.01M $2M +$1.77M +760% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-07
Q1 2019 $249K $2.42M +$2.35M +3257% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-08
Q4 2018 -$2.1M -$2.64M Oct 1, 2018 Dec 31, 2018 10-K 2020-03-06
Q3 2018 $242K Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-05
Q2 2018 $232K Apr 1, 2018 Jun 30, 2018 10-Q 2019-07-31
Q1 2018 $72K Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.